Lv5
1200 积分 2024-12-24 加入
In vivo CAR engineering for immunotherapy
8个月前
已完结
in vivo CAR T cell generation to treat cancer and autoimmune disease
8个月前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
8个月前
已关闭
A first-in-human study of MT-303, an innovative in vivo mRNA chimeric antigen receptor (CAR) therapy targeting GPC3, in adults with hepatocellular carcinoma
8个月前
已完结
Oligonucleotide‐Linked Lipid Nanoparticles as a Versatile mRNA Nanovaccine Platform
8个月前
已完结
Unleashing the Potential: Designing Antibody-Targeted Lipid Nanoparticles for Industrial Applications with CMC Considerations and Clinical Outlook
8个月前
已完结
A first-in-human study of MT-303, an innovative in vivo mRNA chimeric antigen receptor (CAR) therapy targeting GPC3, in adults with hepatocellular carcinoma
9个月前
已关闭
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
9个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
9个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
9个月前
已完结
皖公网安备34019202002308
